Editorial |

Pitfalls of Evidence-Based Medicine:  The Example of Actinic Keratosis Therapy

Barbara A. Gilchrest, MD; George Martin, MD
Arch Dermatol. 2012;148(4):528-530. doi:10.1001/archdermatol.2011.3042.
Text Size: A A A
Published online


No one can argue about the merit of evidence-based medicine. Rigorously quantifying the safety and efficacy of the medications and devices used to treat our patients allows for well-informed decisions and allocation of limited resources. This is as true for dermatology as for other medical and surgical disciplines. Evidence-based medicine promises to eliminate both intentional bias and the frequent misimpressions born of a physician's limited personal experience. The gold standard, level A evidence obtained in prospective, randomized, double-blind, placebo-controlled, properly powered trials is free of the many problems that confound interpretation of the all-too-common retrospective, nonrandomized, unblinded, and/or uncontrolled studies or reports of anecdotal experience that have made up much of the medical literature in the past. The Archives, in a manner characteristic of most first-tier clinical journals, gives strong preference to evidence-based articles and indeed requires in several categories of submissions that the level of evidence underlying specific conclusions or recommendations be explicitly detailed. Is there a problem?

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Evidence-based medicine: facial skin malignancy. Plast Reconstr Surg 2013;132(6):1631-43.